Penumbra Inc
(NYSE:PEN)
$
209.63
0.89 (0.43%)
Market Cap: 8.14 Bil
Enterprise Value: 8.00 Bil
PE Ratio: 616.56
PB Ratio: 7.01
GF Score: 86/100 Penumbra Inc at Wells Fargo Healthcare Conference Transcript
Sep 06, 2023 / 12:00PM GMT
Release Date Price:
$279.06
(+6.47%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good morning, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to kick off our 2023 health care conference with Penumbra. With us this morning, we have Adam Elsesser, Chairman, President and CEO; Jason Mills, Executive Vice President of Strategy; and Jee Hamlyn-Harris, Head of Investor Relations.
In terms of format, it's going to be a fireside chat. If anybody has a question they want to ask, just raise your hand, and we'll come around with the mic. So Adam, thanks so much for being here.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Thank you for having us.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So Adam, I wanted to start off -- I always like to start off with a big picture question. And you gave a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot